N- (1, (1) reacts with arylidinecyanothioacetamides 2a-c in ethanol/piperidine solution under reflux to yield the pyridine-2(1H)-thiones 5a-c. Compound 5a reacts with α-haloketones 6a-e to give the nicotinamide derivatives 7a-e, which cyclized to thienopyridine derivatives 8a-e. The reaction of compound 8a with formamide, phenyl isothiocyanate and hydrazine hydrate afforded the pyridothienopyrimidine derivatives 9, 11 and thienopyridine carbohydrazide derivative 12 respectively. Also, the reaction of 12 with phenyl isothiocyanate under reflux gave the thienopyridine derivative 14. Condensation of 8b,c with DMF-DMA afforded the corresponding 3-[(dimethylamino)methylene)-amino]thienopyridine derivatives 15a,b, which cyclized into the pyridothienopyrimidine derivatives 16a,b. Self coupling of compounds 8b,c were occurred through their diazotization where, the corresponding pyridothienotriazine derivatives 17a,b were obtained. Most of the target compounds were then evaluated for their antimicrobial and antifungal activities.
Introduction
Since the antipyrine (AP) was first synthesized by Knorr 1 in 1883, there has been a continued interest in the studies of antipyrine derivatives (APDs). Up to now, broad properties of APDs have been investigated and reported in many fields. In bifunctional compounds, broad bioactivities of APDs as antitumor 2 , antimicrobial 3 , antiviral 4 , analgesic, anti-inflammatory drugs 5 , and anticancer activity 6 have been investigated. On the other hand, pyridine-2(1H)-thione compounds have gained considerable interest due to their importance as intermediates for the synthesis of the biologically active deazafolic acid and deaza amino protein ring system 7 . Moreover, pyridine carbonitriles were used as cardiotonic 8 and antiviral agents 9 . Furthermore, S-substituted thiopyridines possess neurotropic 10 , cardiovascular 11 , antimicrobial 12 activities and are used as adenosine receptor ligands 13 . Also, nicotinate derivatives have been reported to be used as agrochemical fungicides 14 and anticancer 15 agents.
Moreover, several thienopyridines have been synthesized and their pharmaceutical medicinal activities evaluated and used as anticoagulants 16 , antiartherossclerotics 17 and gonaodotropin releasing hormone antagonists 18 . Also, thieno [2,3-b] pyridines possess a wide range of biological activities such as antiviral 9, 19 , antidiabetic 20 , antimicrobial 12, 21 , antitumor 22 antiparasitic 23 . In addition, pyridothienopyrimidines have been reported to have antiallergic 24 antiprotozoal 25 , antianaphylactic 26 , and antimicrobial 12, 27 activities. Moreover, pyridothienotriazines have been used as antiprotozoal 28 antitumor 29 , antiangiogenic 30 , and antimicrobial 11 agents and have been reported to inhibit NO and eicosanoid biosynthesis 31 .
As a continuation of our program dealing with application of β-oxoanilide in the synthesis of pyridine derivatives 32, 33 and fused pyridines 34 and in conjunction with this work we report here the results of our investigation on the synthesis of new nicotinamides, thieno [2,3-b] pyridines, pyridothienopyrimidines, and pyridothienotriazienes using pyridine-2(1H)-thiones containing antipyrine moiety.
The newly synthesized compounds were evaluated as antimicrobial agents against gram positive, gram negative bacteria and fungi. 35 easily reacted with arylidine cyanothioacetamide derivatives 2a-c in refluxing ethanol containing few drops of piperdine to give the pyridine-2(1H) -thiones 5a-c. Establishing the exact structure of the reaction products is based on the spectroscopic data. The reaction of pyridinethione derivative 5a with α -haloketones 6a-e in ethanol containing piperidine afforded the S-alkylnicotinamide derivatives 7a-e. The structure of compounds 7a-e has been confirmed as the correct one based on its spectral data and elemental analyses. Thus, the IR spectrum of compound 7a, for example, indicated the presence of the absorption band of the CN functional group at υ 2217cm −1 and a carbonyl ester at υ 1715 cm −1 . The 1 H NMR spectrum of compound 7a revealed a triplet signal at δ 1.24 ppm, J=7.2 Hz assigned to ester CH 3 , quartet signal at δ 4.18 ppm, J =7.2 Hz assigned to CH 2 ester, SCH 2 protons at δ =5.48 ppm, in addition to the other protons assigned in compound 7a and the disappearance of the proton of one NH (δ = 13.59 ppm in compound 5a). The structures of 7a-e were further elucidated via elemental analysis and their cyclization into the corresponding thieno [2,3-b] pyridine derivatives 8a-e upon treatment with ethanolic sodium ethoxide under reflux. The structures of 8a-e were confirmed based on elemental analysis and spectral data (Scheme 2 and Experimental data). The IR spectrum of compound 8a exhibited the disappearance of the absorption band due to the CN function group and the appearance of absorption band due to the NH 2 functional group at υ 3470, 3388 cm any signals may be attributed to (CO 2 C 2 H 5 ) and NH 2 protons, and appearance signals assigned to 2NH. Furthermore, the structure of compound 11 was supported by 13 C NMR spectrum (Scheme 3 and Experimental part). The reactivity of β-amino ester derivative 8a toward some electrophilic reagents has been studied. Thus, the reaction of 8a with hydrazine hydrate afforded 3-aminothieno [2,3-b] pyridine carbohydrazide derivative 12. The structure of hydrazide 12 was compatible with the spectroscopic data (IR and 1 H NMR). Also, the reaction, of 12 with phenyl isothiocyanate in dry dioxane under reflux gave the corresponding 3-amino-2-(5-phenylamino-1,3,4-oxadiazol-2-yl)thieno[2,3-b] pyridine derivative 14 via the loss of one molecule of hydrogen sulfide 36 through the formation of the intermediate 13 as reported in literature 36 . The analytical and spectral data are in agreement with the proposed structure (Scheme 3 and Experimental part).
Results and Discussion

It has been found that N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-
4-yl)-3-oxobutanamide (1)
This work was extended to study the reactivity of the amino group in compounds 8b,c as nucleophile. Thus, 8b reacted with dimethylformamide-dimethylacetal (DMF-DMA) in dry dioxan to afford the corresponding 4-(4-chlorophen-yl)- Twelve compounds from the newly synthesized were screened in vitro for their antibacterial activity against Gram positive bacteria; Staphylococcus aureus and Gram negative bacteria; Klebsiella pneumonia. Also, the antifungal activity against Aspergillus flavus and Aspergillus ochraceous was evaluated using the agar diffusion technique 37 . 1mg/ml solution in dimethylformamide (DMF) was used. The bacteria and fungi were grown on nutrient agar and Czapek's-Dox agar media, respectively. DMF as a negative control did not show inhibition zones. The agar media were inoculated with different microorganism ' s culture tested after 24 hours of inoculated at 37°C for bacteria and for antifungal tested after 72 hours of inoculated at 28°C, The diameter of inhibition zone (mm) was measured.
Most of the synthesized compounds were found to possess various antimicrobial activities towards all the microorganisms used ( Table 1) . Compounds 8b was found to possess highest antibacterial activity toward Staphylococcus aureus (G +ve), compound 17a was found to be very active against aspergillus flavus. In addition, compounds 5a, 8a, 11 revealed a moderate activity against Staphylococcus aureus (G +ve). Compounds 7b, 11, 16a, 17a showed a moderate activity against Klebsiella pneumonia (G -ve), compounds 5a, 8a, 9 and 15a showed a moderate activity against aspergillus flavus. Moreover, compounds 7a, 7b, 9, 14, 16a, 17a were found to have low activity against Staphylococcus aureus (G +ve), compounds 5a, 8a, 8b, 9, 12 and 15a were found to be the low activity against Klebsiella pneumonia (Gve). Whereas compounds 7a, 8b, 12, 16a showed a low activity against aspergillus flavus and compounds 7b, 8b, 9, 11, 14 and 16a showed a low activity against Aspergillus ochraceous.
Table1. Antimicrobial activity of some of the newly synthesized compounds. 
Inhibition Zone = 0.1 -0.5 cm beyond control = + (slightly active); Inhibition Zone = 0.6 -1.0 cm beyond control = + + (moderately active); Inhibition Zone = 1.1 -1.5 cm beyond control = + + + (highly active); Inhibition Zone = 0.0 cm beyond control = − (inactive).
Experimental
All melting points are uncorrected. IR spectra (KBr) were recorded on a FTIR 5300 spectrometer (, cm -1 ). The 1 H NMR and 13 C-NMR spectra were recorded in DMSO-d 6 at 200, 300 MHz on a Varian Gemini NMR spectrometer (, ppm) using TMS as an internal standard. Elemental analysis were carried out by the Micro analytical Research Center, Faculty of Science, Cairo University, Assiut University and Al-azhar university, faculty of science, Department of chemistry, Assiut branch.
Preparation of Compounds 5a-c: General Procedure
A mixture of compound 1 (0.01 mol) and arylidinecyanothioacetamide 2a-c (0.01mol) in ethanol (30 mL) was treated with piperidine (0.5 mL) and heated under reflux for 7 h. The reaction mixture was then cooled by being poured into crushed ice and acidified with HCl. The solid product was collected and recrystallized from ethanol to give compounds 5a-c. 
4-(4-
5-Cyano-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-4-(4-methoxyphenyl)-2-methyl-6-thioxo-1,6-dihydropyridine-3-carboxamide (5c)
Preparation of Compounds 7a-e: General Procedure
A mixture of compound 5a (0.01 mol), halo compounds 6a-e (0.01 mol), and piperidine (0.5 mL) in ethanol (30 mL) was heated under reflux for 3 h, then cooled, poured into crushed ice, and acidified with HCl. The precipitates formed were collected and recrystallized from the proper solvent to give 7a-e. (4-chlorophenyl)-3-cyano-5-((1,5-dimethyl-3-oxo-2-phenyl-2,3- N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-methyl-6-((2-oxo-2-((4-(N-(pyrimidin-2-yl) 2-((4-chlorophenyl)amino)-2-oxoethyl)thio)-5-cyano-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl) 
Ethyl2-((4-
dihydro-1H-pyrazol-4-yl)carbamoyl)-6-methylpyridin-2-yl)thio)acetate (7a)
4-(4-Chlorophenyl)-5-cyano-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-methyl-6-((2-oxo-2-((4-sulfamoylphenyl) amino) ethyl) thio)nicotinamide (7b)
4-(4-Chlorophenyl)-5-cyano-
4-(4-Chlorophenyl)-5-cyano-6-((cyanomethyl)thio)-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-methylnicotinamide (7d)
4-(4-Chlorophenyl)-6-((
Preparation of Compounds 8a-e: General Procedure
Solutions of each of 7a-e (0.01) in ethanol and sodium ethoxide (0.01mol Na in 10 mL ethanol) were heated under reflux for 6 h, then left to stand at room temp., poured into cold water, and acidified with HCl. The product Formed was collected by filtration and recrystallized from the proper solvent to afford 8a-e. -4-(4-chlorophenyl)-N  5 -(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-6-methyl-N2-(4-(N-(pyrimidin-2-yl)sulfamoyl)-phenyl)  thieno[2,3-b]pyridine-2,5-dicarboxamide (8c A solution of compound 8a (0.01 mol) in formamide (10 mL) was heated under reflux for 5 h, then allowed to cool and poured into cold water. The solid product was collected and crystallized from ethanol / dioxan to give 9 as green crystals, yield 61%; mp > 300 Chlorophenyl)-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-7-methyl-4-oxo-3-phenyl-2-thioxo-1,2,3,4-tetrahydro-pyrido[3',2 To a solution of compound 12 (0.01 mol) in dry dioxane 30 mL, phenyl isothiocyanate (0.01 mol) was added. The mixture was heated under reflux for 15 h. The solid product that formed after cooling was collected by filtration and recrystallized from dioxane / ethanol to give 14 (60%) as brown crystals, mp > 300 
3-Amino
9-(4-
Preparation of Compounds 15a,b: General Procedure
A solution of the appropriate 8b,c (0.01 mole) in dry dioxan (30 ml) and DMF-DMA (0.015 mole) was heated under reflux for 4 h. The reaction mixture was then cooled. The solid products so formed were filtered off and crystallized from dioxan to yield 15a, b. A solution of the appropriate formamidine derivatives 15a,b (0.01 mole) in glacial acetic acid (30 ml) was heated under reflux for 6 h. The reaction mixture was then cooled. The solid products so formed were filtered off and crystallized from ethanol /dioxane to yield 16a, b.
4-(4-
Method B: Reaction of 8b,c with Concentrated formic acid:
A solution of the appropriate 8b,c (0.01 mole) in glacial acetic acid (30 ml) was treated with anhydrous formic acid (5 ml) and then heated under reflux for 6 h. The Chlorophenyl)-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-7-methyl-4-oxo-3-(4-(N-(pyrimidin-4-yl) 
9-(4-
